Senior insider sale
President, Chief Medical Off at TRAWS PHARMA, INC. — senior position signals high conviction
$6.2K
9.21K shares
What this filing means
FRUCHTMAN STEVEN M plans to sell 9.21K shares of TRAWS PHARMA, INC. valued at approximately $6.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/8/2024ACC: 0001950047-24-000741
Officer· President, Chief Medical Off
Since Jul 2018
9.21K
Shares to sell
$6.2K
Approx. market value
9.21K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Employee stock unit award(s)
2/7/2024
9.21KTotal acquired9.21K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/7/2024 | Restricted stock vesting under a registered plan Employee stock unit award(s) | 9.21K | — |
| Total | 9.21K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
9.21K
Market value
$6.2K
2/8/2024
Total
Units
9.21K
Value
$6.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/8/2024 | 9.21K | $6.2K | NASDAQ | Planned |
| Total | 9.21K | $6.2K | ||